HonorHealth Breast Cancer Symposium 2019 · 2019-09-18 · HonorHealth invites you to a breast...
Transcript of HonorHealth Breast Cancer Symposium 2019 · 2019-09-18 · HonorHealth invites you to a breast...
Ho
norH
ealth
invi
tes
you
to a
bre
ast h
ealth
sym
po
sium
fr
om
7:4
5 a
.m. -
2:0
0 p
.m. S
atur
day
, Oct
. 26
.
The
sym
po
sium
focu
ses
on
clin
ical
info
rmat
ion
fro
m e
arly
det
ectio
n to
su
rviv
ors
hip
for
the
pri
mar
y ca
re p
rovi
der
, inc
lud
ing
:
• Th
e ut
iliza
tion
of n
atio
nal g
uid
elin
es a
roun
d b
reas
t can
cer
scre
enin
g
and
ear
ly d
etec
tion
for
at-r
isk
pat
ient
s.
• U
nder
stan
din
g a
vaila
ble
trea
tmen
t op
tions
whi
le re
cog
nizi
ng th
e im
po
rtan
ce o
f the
PC
P in
ong
oin
g c
olla
bo
rativ
e ca
re p
lann
ing
.
• Re
cog
nizi
ng b
est c
are
pra
ctic
es fo
r b
reas
t can
cer
pat
ient
s, d
urin
g
and
aft
er tr
eatm
ent.
Cha
teau
Lux
e 11
75 E
. Lo
ne C
actu
s D
rive
Pho
enix
, AZ
8502
4
Ho
norH
ealt
h.co
mE.
LONE
CACTU
S DR.
E. DE
ER VA
LLEY
DR.
N. 7TH STREET
Reg
iste
r o
nlin
e at
: my.
hono
rhea
lth.c
om
/bre
ast-
canc
er-s
ymp
osi
um-2
01
9Th
is c
onf
eren
ce h
as b
een
app
rove
d b
y th
e A
SRT
for
4.5
Cat
ego
ry A
CEs
. Att
end
ees
mus
t be
pre
sent
for
all
lect
ures
to re
ceiv
e cr
edit.
HonorHealth Breast Cancer Symposium 2019
You’re invited to a symposium on breast health.
Breast Cancer: From Early Detection to Survivorship
The symposium focuses on clinical information from early detection to survivorship for the primary care provider.
Saturday, Oct. 26, 2019 7:45 a.m. - 2:00 p.m.• FREE Event
• Limited seating; register soon
• Refreshments and lunch included
Register online at: my.honorhealth.com/breast-cancer-symposium-2019
PO B
OX
905
4 PH
OEN
IX, A
Z 85
068
-905
4
Bre
ast H
ealth
Sym
pos
ium
Welcome and opening remarks Brendan Curley, DO, Conference Co-Director and Sommer Gunia, DO, Conference Co-Director
Breast cancer management for clinicians: What’s new in screening, prevention and managementJame Abraham, MD, Keynote SpeakerLEARNING OBJECTIVES:• Overview of breast cancer diagnosis and
management.• Relevant new information for Primary Care Physicians.
Questions
Breast imaging and biopsySarah Palestrant, MD, RadiologistLEARNING OBJECTIVES:• Explain the role of imaging in the screening,
detection, clinical staging and treatment assessment of breast cancer.
• Describe the importance of 3D Tomography and Ultrasound with screening.
• Discuss the relationship between breast density and risk of breast cancer.
Pathologic diagnosing and molecular testing of breast cancerChristopher Stasik, DO, PathologistLEARNING OBJECTIVES:• Summarize the pathologic evaluation and staging of
breast cancer. • Distinguish between benign, malignant and
indeterminate lesions as it relates to management or treatment.
Questions
Surgical approaches to breast cancer treatment Linda Liu, MD, General SurgeonLEARNING OBJECTIVES:• Review current surgical treatments for breast
cancer, including indications for lumpectomy versus mastectomy.
• Discuss indications for prophylactic mastectomy.
Reconstructive procedures available for patients undergoing surgical interventionsClay Forsberg, MD, Reconstructive SurgeonLEARNING OBJECTIVES:• Discuss the importance of reconstructive surgery and
its timing. • Highlight oncoplastic procedures recommended after
a lumpectomy.
Questions
PRESENTATION TOPICSBreast Cancer: From Early Detection to Survivorship
Michael Janicek, MDJasgit Sachdev, MD
Acknowledgment: This CME event is not supported by any commercial entity or joint partnership.
Disclosure: Michael Janicek, MD, has disclosed he is involved in consulting and speaking activities for Astra Zeneca, Clovis Oncology, Tesaro and GSK. Robert Kuske, MD, has disclosed that he received an educational grant from Elekta. Linda Liu, MD, has disclosed she is on the speaker’s bureau for Myriad Genetics. Jasit Sachdev, MD, has disclosed she has received grant/research support from Merck and Salarius and received honoraria from Tempus, Novartis, Ipsen, and Puma. All other speakers and members of the planning committee have no relevant financial relationships with a commercial interest to disclose.
Accreditation Statement: HonorHealth is accredited by the Arizona Medical Association (ArMA) to provide continuing medical education for physicians.
Credit Statement: HonorHealth designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
SYMPOSIUM PRESENTERS
Medical oncology management of breast cancer Brendan Curley, DO, Medical OncologistLEARNING OBJECTIVES:• Discuss current breast cancer therapies based on
evidence-based national guidelines and prognostic indicators.
• Review options to reduce chemotherapy side effects.
Radiation oncology management of breast cancer Robert Kuske, MD, Radiation OncologistLEARNING OBJECTIVES:• Discuss current radiation therapies for breast cancer
treatment based on national guidelines. • Explain partial breast radiation and intraoperative
radiation.
Fertility preservation for women of childbearing potential Shane Lipskind, MD, EndocrinologistLEARNING OBJECTIVES:• Review options and importance of fertility
preservation prior to treatment. • Understand the implications of pregnancy after
cancer and testing embryos for BRCA mutations.
Questions
Working Lunch - Diet and nutrition as it relates to breast cancer Terri Taylor, RD, Nutrition LEARNING OBJECTIVES:• Review diet recommendations to reduce breast
cancer risk.• Discuss nutrition recommendations during and after
treatment.• Educate on resources/options available for patients
undergoing therapy for breast cancer.
Identification and management of high-risk patients Jasgit Sachdev, MD, Hematologist/Oncologist Early Detection LEARNING OBJECTIVES:• Discuss importance of early detection and
recognizing the high-risk patient.• Illustrate pathways for high-risk management
including risk reduction or increased surveillance.
Understanding genetic implications of breast cancer Michael Janicek, MD, Oncologist LEARNING OBJECTIVES:• Review the importance of family history and genetic
counseling.• Define B1 and B2 positive mutations.• Provide insight into surveillance and risk reduction
surgery.
Questions
Tumor Board Panel Discussion LEARNING OBJECTIVES:• Real time treatment planning.• Highlight the multidisciplinary collaboration in
treatment planning decisions.
Wrap up and evaluations
12892_0819
Linda Liu, MDSarah Palestrant, MD Christopher Stasik, DO Clay Forsberg, MD
Terri Taylor, RDRobert Kuske, MD Shane Lipskind, MD
CONFERENCE CO-DIRECTORSKEYNOTE SPEAKER
Brendan Curley, DO Sommer Gunia, DOJame Abraham, MD